Thursday , August 18 2022

An experimental Alzheimer's vaccine can reduce the number of demons



[ad_1]

A breakthrough in the treatment of dementia?

Researchers have now found that experimental Alzheimer's vaccine can reduce the number of cases of dementia and inhibit the effects of degenerative brain disease by five years.

Researchers at the University of Texas Medical Center at the Texas Medical Center have found that experimental Alzheimer's vaccine can significantly reduce the number of dementia cases. The doctors published their results in the journal Alzheimer's Research and Therapy in English.

A new drug can reduce the number of cases of dementia in the future. (Photo: Photographee.eu / fotolia.com)

Vaccines have shown promising results in animal experiments

The new vaccine has shown promising results in recent animal experiments, experts say. The researchers hope the vaccine will also have similar effects in humans. The path from animal testing to human use is long and exhausting, and many promising drugs do not. If the vaccine proves safe and effective during human trials, it may reduce the total number of dementia diagnoses by half, researchers explain.

Vaccinations of Alzheimer's often caused harmful side effects

Dementia is the general term used to describe symptoms of cognitive decline involving problems in memory, thinking, and behavior. Alzheimer's is the leading cause of dementia, doctors say. The new experimental vaccine marks a monumental boost in the fight against dementia. Earlier, Alzheimer's vaccines caused harmful side effects, including inflammation of the brain, the authors say.

Successful first tests completed!

Recent tests on monkeys and rabbits have now determined that the new vaccine stimulates the body to produce antibodies to reduce the accumulation of amyloid and tau. Both of these proteins usually indicate degenerative brain disease. The vaccine can prolong people's lives and prevent the spread of the disease to the brain, researchers say.

The vaccine appears to prevent the accumulation of proteins

If the drug can delay the onset of the disease in five years, it would be a huge step forward for the patients and their families. This can reduce the number of dementia cases by half. The new vaccine appears to be able to stop the accumulation of abnormal protein structures in the brain, resulting in nerve cell death without causing autoimmune inflammation, the researchers write in a press release from the University of Texas Medical Center.

Does Herpes Cause Alzheimer's?

According to the Alzheimer's Association, the disease is the sixth most common cause of death in the US About 5.7 million Americans currently live with Alzheimer's disease, and researchers estimate the number will increase to 14 million by 2050. Between 2000 and 2015, 1. 2. 3%.

A University of Manchester professor recently said that about half of Alzheimer's disease is caused by herpes viruses. A connection that was unknown until now. According to the World Health Organization (WHO), about 3.7 billion people under the age of 50 (more than 50 percent of the world population) carry the herpes simplex virus type 1 in their bodies. (as)

[ad_2]
Source link